Brainstem pathology in DYT1 primary torsion dystonia

Annals of Neurology

Volumn 56, Issue 4, 2004, Pages 540-547

  McNaught, Kevin St P ^a   Kapustin, Alexander ^a   Jackson, Tehone ^a   Jengelley, Toni Ann ^a   JnoBaptiste, Ruth ^a   Shashidharan, Pullanipally ^a   Perl, Daniel P ^a   Pasik, Pedro ^a   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; LAMIN A; LAMIN C; MEMBRANE PROTEIN; TAU PROTEIN; TORSIN A PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN STEM; CASE REPORT; CELL INCLUSION; CHOLINERGIC NERVE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCUS CERULEUS; MALE; MESENCEPHALON; MESENCEPHALON RETICULAR FORMATION; NERVE CELL; PATHOLOGY; PEDUNCULAR ANSA; PERIAQUEDUCTAL GRAY MATTER; PONS ANGLE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; TORSION DYSTONIA;

ADULT; AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; BLOTTING, WESTERN; BRAIN STEM; CHOLINE O-ACETYLTRANSFERASE; DYSTONIA MUSCULORUM DEFORMANS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; LAMIN TYPE A; LOCUS COERULEUS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR CHAPERONES; MUTATION; NERVE TISSUE PROTEINS; POSTMORTEM CHANGES; PROTEIN DISULFIDE-ISOMERASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNUCLEINS; TAU PROTEINS; UBIQUITIN;

EID: 4844225770     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20225     Document Type: Article

References (34)

1. Bressman SB. Dystonia genotypes, phenotypes, and classification. Adv Neurol 2004;94:101-107.
2. Ozelius L, Kramer PL, Moskowitz CB, et al. Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron 1989;2:1427-1434.
3. Ozelius LJ, Hewett JW, Page CE, et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997;17:40-48.
4. Konakova M, Huynh DP, Yong W, Pulst SM. Cellular distribution of torsin A and torsin B in normal human brain. Arch Neurol 2001;58:921-927.
5. Rostasy K, Augood SJ, Hewett JW, et al. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol Dis 2003;12:11-24.
6. Shashidharan P, Kramer BC, Walker RH, et al. Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res 2000;853:197-206.
7. Walker RH, Brin MF, Sandu D, et al. Distribution and immunohistochemical characterization of torsinA immunoreactivity in rat brain. Brain Res 2001;900:348-354.
8. Kamm C, Boston H, Hewett J, et al. The early onset dystonia protein torsinA interacts with kinesin light chain 1. J Biol Chem 2004;279:19882-19892.
9. Shashidharan P, Paris N, Sandu D, et al. Overexpression of torsinA in PC12 cells protects against toxicity. J Neurochem 2004;88:1019-1025.
10. Sherman MY, Goldberg AL. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 2001;29:15-32.
11. Ciechanover A, Brundin P. The ubiquitin proteasome system in neurodegenerative diseases. Sometimes the chicken, sometimes the egg. Neuron 2003;40:427-446.
12. Walker RH, Brin MF, Sandu D, et al. TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia. Neurology 2002;58:120-124.
13. McNaught KS, Shashidharan P, Perl DP, et al. Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 2002;16:2136-2148.
14. Haas AL, Bright PM. The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates. J Biol Chem 1985;260:12464-12473.
15. McLean PJ, Kawamata H, Shariff S, et al. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem 2002;83:846-854.
16. Kuner R, Teismann P, Trutzel A, et al. TorsinA protects against oxidative stress in COS-1 and PC12 cells. Neurosci Lett 2003;350:153-156.
17. Hewett J, Gonzalez-Agosti C, Slater D, et al. Mutant torsinA, responsible for early-onset rorsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet 2000;9:1403-1413.
18. Baptista MJ, O'Farrell C, Hardy J, Cookson MR. Microarray analysis reveals induction of heat shock proteins mRNAs by the torsion dystonia protein, TorsinA. Neurosci Lett 2003;343:5-8.
19. Gonzalez-Alegre P, Paulson HL. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J Neurosci 2004;24:2593-2601.
20. Hewett J, Ziefer P, Bergeron D, et al. TorsinA in PC12 cells: localization in the endoplasmic reticulum and response to stress. J Neurosci Res 2003;72:158-168.
21. Kustedjo K, Bracey MH, Cravatt BF. Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J Biol Chem 2000;275:27933-27939.
22. Goodchild RE, Dauer WT. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci USA 2004;101:847-852.
23. Naismith TV, Heuser JE, Breakefield XO, Hanson PI. TorsinA in the nuclear envelope. Proc Natl Acad Sci USA 2004;101:7612-7617.
24. Takakusaki K, Habaguchi T, Ohtinata-Sugimoto J, et al. Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction. Neuroscience 2003;119:293-308.
25. Takakusaki K, Oohinata-Sugimoto J, Saitoh K, Habaguchi T. Role of basal ganglia-brainstem systems in the control of postural muscle tone and locomotion. Prog Brain Res 2004;143:231-237.
26. Jordan LM. Initiation of locomotor in mammals. Ann NY Acad Sci 1998;860:83-89.
27. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000;123:1767-1783.
28. Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 1987;84:5976-5980.
29. Zweig RM, Jankel WR, Hedreen JC, et al. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 1989;26:41-46.
30. Kojima J, Yamaji Y, Matsumura M, et al. Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey. Neurosci Lett 1997;226:111-114.
31. Kelland MD, Asdourian D. Pedunculopontine tegmental nucleus-induced inhibition of muscle activity in the rat. Behav Brain Res 1989;34:213-234.
32. Lai YY, Siegel JM. Muscle tone suppression and stepping produced by stimulation of midbrain and rostral pontine reticular formation. J Neurosci 1990;10:2727-2734.
33. Young RF, Tronnier V, Rinaldi PC. Chronic stimulation of the Kolliker-Fuse nucleus region for relief of intractable pain in humans. J Neurosurg 1992;76:979-985.
34. Zweig RM, Hedreen JC, Jankel WR, et al. Pathology in brainstem regions of individuals with primary dystonia. Neurology 1988;38:702-706.